Label: CODEINE-GUAIFENESIN- codeine phosphate and guaifenesin solution

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: CV
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated May 26, 2021

If you are a consumer or patient please visit this version.

  • Active ingredient

    (in each teaspoonful (5 mL))
    Codeine Phosphate USP 10 mg

  • Purpose

    Antitussive

  • Active ingredient

    (in each teaspoonful (5 mL))
    Guaifenesin USP 100 mg

  • Purpose

    Expectorant

  • Uses

    temporarily relieves:
    cough due to minor throat and bronchial irritation as may occur with a cold or inhaled irritants
    your cough to help you sleep
    helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and makes cough more productive.
  • Warnings

    Ask your doctor before use if

    you have a persistent cough, this may be a sign of a serious condition
    you have a persistent cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
    you have a cough that is accompanied by excessive phlegm (mucus)
    you have chronic pulmonary disease or shortness of breath
    giving to a child who is taking other drugs

    When using this product

    giving a higher dose than recommended by a doctor could result in serious side effects for your child. A special measuring device should be used to give an accurate dose of this product to children under 6 years of age.
    may cause or aggravate constipation

    Stop use and ask a doctor if

    symptoms do not improve within 7 days, tend to recur or are accompanied by fever and rash or persistent headache. These may be symptoms of a serious condition.

    If pregnant or breast-feeding

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    do not exceed 6 doses in 24 hours.

    Adults and children
    12 years of age and over: 

    2 tsp (10 mL) every 4 hours, or as directed by a doctor. 

    Children 6 to under
    12 years of age:

    1 tsp (5 mL) every 4 hours, or as directed by a doctor.

    Children under
    6 years of age:

    Consult a doctor.

  • Other information

    Store at controlled room temperature 15°-30°C (59°-86°F).

  • Inactive ingredients

    Cherry Flavor, Citric Acid, Glycerin, Polyethylene Glycol, Purified Water, Sodium Citrate, Sodium Saccharin, Sorbitol.

  • Principal Display Panel

    NDC 68788-7235-1
    Codeine-Guaifenesin Oral Solution
    10-100 mg/5 mL
    Antitussive
    Expectorant

    Guaifenesin & Codeine Oral Sol. 10-100mg/5mL
  • INGREDIENTS AND APPEARANCE
    CODEINE-GUAIFENESIN 
    codeine phosphate and guaifenesin solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-7235(NDC:58657-500)
    Route of AdministrationORALDEA ScheduleCV    
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CODEINE PHOSPHATE (UNII: GSL05Y1MN6) (CODEINE ANHYDROUS - UNII:UX6OWY2V7J) CODEINE PHOSPHATE10 mg  in 5 mL
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN100 mg  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    SORBITOL (UNII: 506T60A25R)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorCHERRYImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68788-7235-1120 mL in 1 BOTTLE; Type 0: Not a Combination Product08/07/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34108/07/2018
    Labeler - Preferred Pharmaceuticals Inc. (791119022)
    Registrant - Preferred Pharmaceuticals Inc. (791119022)
    Establishment
    NameAddressID/FEIBusiness Operations
    Preferred Pharmaceuticals Inc.791119022RELABEL(68788-7235)